Category English

WHO Issues First List Of Potential Deadly Bacteria If No New Antibiotics Are Found

Microbial resistance to antibiotics has been rising and the world is now facing the serious possibility of falling back to the days when infectious diseases were hardly treatable. The World Health Organization today published a list of bacteria for which new antibiotics are most urgently needed, to help with the race against time, as the medical world is running out of treatment options.

Will US Follow UK Lead In Case On Copyright And Interoperability?

In a case pitting copyright protection against competition, the United States Court of Appeals for the Fourth Circuit must decide whether World Programming Limited (WPL) violated SAS Institute's copyright by copying software interfaces that enable interoperability. WPL has already won the argument in the UK and in Europe's highest court. The case has drawn strong support on both sides from the tech sector and a civil liberties group.

WIPO Committee On Protection Of Folklore: Shall We Dance?

It is generally held that traditional cultural expressions reflect communities’ cultural and social background and include elements of their heritage. For indigenous and local communities, those expressions of their traditional culture are vital. Next week, World Intellectual Property Organization committee members are expected to advance on a draft treaty text to protect those expressions, and look for ways to agree on basic principles, such as what the treaty should protect, how, and who it should protect.

German-Backed Report Lays Out Strategy For R&D Into New Antibiotics

In the face of the lack of attractiveness of investing in research for new antibiotics for the pharmaceutical industry, and the general lack of funding for research and development for novel antibiotics, a new report commissioned by the German Federal Ministry of Health calls for countries to take action. In particular, the report proposes a global union for research and development, a global research fund, and a global launch reward. And access and pricing are key components of the strategy, it says.

US Business, Government Work To Bring Down ‘Dangerous’ UN Panel Report On Access To Medicines – And Change The Debate In Geneva

Calling it flawed and narrow and seemingly threatened by its contents, the leading United States business group and US government IP specialists are working to limit the impact of a recent United Nations report that made recommendations for the decades-old problem of ensuring affordable medicines reach people when they are under patent in a way that does not threaten innovation. One step in countering the UN report? Change the discourse in Geneva and elsewhere.

Side Event On UN High-Level Panel On Access To Medicines Next Week At WTO

As the World Trade Organization intellectual property committee meeting next week is expected to discuss the report of the United Nations Secretary General’s High-Level Panel on Access to Medicines next week, a group of developing countries is convening a side event to engage in discussion with members of the panel. The report included several direct recommendations to WTO members.